<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28744/data-on-enfortumab-in-post-platinum-and-i-o-bladder-cancer?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Data on Enfortumab in Post-Platinum and I-O Bladder Cancer

Name: Data on Enfortumab in Post-Platinum and I-O Bladder Cancer
Uploaded: 2019-07-01T05:18:39
Duration: 1 min 15 s
Description: Bradley McGregor MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, GU Network Liaison, Dana Farber Cancer Institute explains the data on enfortumab in post-platinum and immuno-oncology (I-O) bladder cancer in patients is impressive enough to possibly change ...

00:01:15

Don

3 years 123 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28744/data-on-enfortumab-in-post-platinum-and-i-o-bladder-cancer?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/28744/data-on-enfortumab-in-post-platinum-and-i-o-bladder-cancer?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/28744/data-on-enfortumab-in-post-platinum-and-i-o-bladder-cancer?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/28744?channelName=obr"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190701171839_af15/video_190701171839_af15.jpg?cache=15669161071678829655">Data on Enfortumab in Post-Platinum and I-O Bladder Cancer</a>

Link (BBCode):

[url=https://oncologytube.com/v/28744?channelName=obr][img]https://oncologytubecom.cdn.ypt.me/videos/video_190701171839_af15/video_190701171839_af15.jpg?cache=15669161071678829655[/img]Data on Enfortumab in Post-Platinum and I-O Bladder Cancer[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Bladder

Description:

Bradley McGregor MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, GU Network Liaison, Dana Farber Cancer Institute explains the data on enfortumab in post-platinum and immuno-oncology (I-O) bladder cancer in patients is impressive enough to possibly change future practice habits.